Skip to content

Clinical trials

Phase 3 Lymphoma, Large B-Cell, Diffuse trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 3 Country / region: Brazil Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20111
20122
20133
20171
20191
20203
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Genmab2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
Acerta Pharma BV1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
M.D. Anderson Cancer Center1
Merck Sharp & Dohme LLC1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse18
Lymphoma6
Lymphoma, Non-Hodgkin6
Lymphoma, B-Cell4
Lymphoma, Follicular2
Neoplasms2
Bronchiolitis Obliterans Syndrome1
Hematologic Neoplasms1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphatic Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.